Clinical Trial Update: Epidemiology of Insulin and Dehydroepiandrosterone Sulfate and Coronary Heart Disease Mortality

View source ↗

Summary

A completed NHLBI study examining the epidemiology of insulin and dehydroepiandrosterone sulfate and their association with coronary heart disease mortality.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease

Drugs mentioned

• DHEA-Sulfate (dehydroepiandrosterone sulfate)
• Insulin (insulin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED